C4 Therapeutics, Inc. ( CCCC) - Stock Earnings
CCCC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
CCCC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -32.2 million USD | 11.2 million USD |
| 2025Q4 | -20.5 million USD | 11.0 million USD |
| 2026Q1 | -25.1 million USD | 6.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CCCC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -132.5 million USD | 20.8 million USD |
| 2024 | -105.3 million USD | 35.6 million USD |
| 2025 | -105.0 million USD | 35.9 million USD |
| 2026 Est. | — | — |
CCCC
Price: $3.40
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 914600
Market Capitalization: 342.9 million